Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Immunodeficiency

Magnesium regulates antiviral immunity

Nature Reviews Immunology volume 13, pages 548–549 (2013)Cite this article

Subjects

The authors studied seven patients with XMEN, all of whom had increased levels of EBV DNA in their blood compared with control individuals, and some of whom had developed lymphoproliferative disorders including lymphoma. NK cells and EBV-specific cytotoxic T lymphocytes (CTLs) from these patients showed defective cytotoxicity against target cells in vitro, which could not be explained by a deficient production of cytotoxic granule proteins or degranulation.

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Chaigne-Delalande, B. et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341, 186–191 (2013)

    CAS  Article  Google Scholar 

Download references

Authors
  1. Kirsty Minton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Minton, K. Magnesium regulates antiviral immunity. Nat Rev Immunol 13, 548–549 (2013). https://doi.org/10.1038/nri3501

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nri3501

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing